Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Observational Study to Evaluate Cardiovascular Outcomes of Patients With Type 2 Diabetes Mellitus Treated With Gemigliptin

NCT02290301 is registered in ClinicalTrials.gov with LG Life Sciences as lead sponsor.

NCT NCT02290301
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02290301 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Observational Study to Evaluate Cardiovascular Outcomes of Patients With Type 2 Diabetes Mellitus Treated With Gemigliptin
Lead sponsor
LG Life Sciences
Phase
Observational
Overall status
Completed
Start date
June 28, 2013
Completion date
November 30, 2017
Enrollment
5,180 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

type 2 diabetes mellitus